ST Pharm Co.,Ltd. (KOSDAQ:237690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Raw Material Manufacturing	244.07B	251.56B	209.27B	139.14B	109.05B
Raw Material Manufacturing Growth	-2.98%	20.21%	50.40%	27.59%	-
Clinical Trial Contract Research	30.36B	33.76B	40.32B	27.16B	15.12B
Clinical Trial Contract Research Growth	-10.07%	-16.26%	48.46%	79.66%	-
Consolidation Adjustment	-681.99M	-326.10M	-263.41M	-652.92M	-55.97M
Total	273.75B	284.99B	249.32B	165.64B	124.11B
Total Growth	-3.94%	14.31%	50.52%	33.47%	33.08%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Korea	33.88B	39.84B	52.57B	45.47B	44.46B
Korea Growth	-14.96%	-24.22%	15.61%	2.28%	-5.94%
Switzerland	95.47B	98.64B	110.25B	61.81B	26.87B
Switzerland Growth	-3.21%	-10.53%	78.39%	129.98%	-
USA	84.74B	51.95B	30.31B	22.52B	20.12B
USA Growth	63.11%	71.42%	34.60%	11.90%	-
Other Countries	59.41B	66.28B	55.54B	35.85B	29.57B
Other Countries Growth	-10.35%	19.34%	54.92%	21.22%	-
Belgium	250.96M	28.28B	658.69M	-	-
Belgium Growth	-99.11%	4194.11%	-	-	-
Spain	-	-	-	-	3.08B
Total	273.75B	284.99B	249.32B	165.64B	124.11B
Total Growth	-3.94%	14.31%	50.52%	33.47%	33.08%

Source: S&P Global Market Intelligence.